Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D
Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs
Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany
A crowded symposium dedicated to the SIPPET Study was held on July 9th
Farmindustria roadshow is hosted by Kedrion
Innovation and Production of Value held on 19th May at our Bolognana production plant
Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017
Global campaign to improve early diagnosis and optimal treatments for PID
Kedrion Biopharma initiatives for World Hemophilia Day 2017
The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over
Kedrion took part in the 17th ESID Meeting with 44 international guests
The conference focused on new insights into PIDs’ diagnosis and therapies
Pharmaceutical digitization: how to improve patient care and engagement
Kedrion Biopharma Advisor Prof. Albert Farrugia lectures at “The Future of Science” Conference in Venice, Italy
SIPPET Study was WHF 2016 World Congress highlight
A Kedrion, Grifols and LFB supported symposium featured a lecture by Dr. Manuel Carcao
Kedrion initiatives for World Hemophilia Day 2016
The goal is to improve access to treatments for people suffering from hemorrhagic conditions